About AppSwarm, Inc. AppSwarm, Inc. is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. View Complete Profile
Global Payout, Inc. (GOHE) Global Payout, Inc. provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. View Complete Profile
About Lexaria Bioscience Corp. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products. View Complete Profile
About Medical Transcription Billing, Corp. Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology. Developed through a NATO-funded project at McMaster University, Patriot One’s disruptive NForce CMR1000 (PATSCAN) technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide. View Complete Profile
About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is currently conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a combination study with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company]. The combination study is listed in ClinicalTrials.gov as NCT03328026. BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, which is expected to cover over 90 percent…
About Kootenay Zinc Corp. Kootenay Zinc is a Vancouver, British Columbia-based mineral exploration & development company focused on discovering large-scale sedimentary-exhalative (“SEDEX”) zinc deposits. View Complete Profile
About India Globalization Capital, Inc. IGC’s strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. View Complete Profile
About ORHub, Inc. ORHB is a cloud-based software platform designed to transform the business of surgery into a value-based model, empowering care providers at every stage of the surgical process. View Complete Profile
Singlepoint, Inc. (SING) SING provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. View Complete Profile
Stealth Technologies, Inc. STTH is focused on cost effective, independently validated solutions for large addressable international and domestic markets, with its primary target being identity protection and personal safety, via offerings like its Stealth Card identity theft device. View Complete Profile
Bitcoin
Bitcoin Cash
Ethereum
Litecoin
USD Coin
Copyright . NetworkNewsWire® / 1202 Lexington Ave. Suite 117 New York, NY 10028 (212) 418-1217 / Disclaimers
